Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$113.0 - $153.43 $101,700 - $138,087
900 New
900 $134,000
Q1 2024

May 15, 2024

SELL
$123.45 - $159.4 $49,380 - $63,760
-400 Reduced 14.29%
2,400 $362,000
Q4 2023

Feb 14, 2024

BUY
$86.1 - $127.36 $111,929 - $165,568
1,300 Added 86.67%
2,800 $352,000
Q3 2023

Nov 14, 2023

SELL
$86.5 - $103.97 $198,950 - $239,131
-2,300 Reduced 60.53%
1,500 $140,000
Q2 2023

Aug 14, 2023

SELL
$69.96 - $97.84 $342,803 - $479,416
-4,900 Reduced 56.32%
3,800 $339,000
Q1 2023

May 15, 2023

BUY
$104.9 - $126.78 $157,350 - $190,170
1,500 Added 20.83%
8,700 $932,000
Q4 2022

Feb 14, 2023

BUY
$99.42 - $131.97 $437,448 - $580,668
4,400 Added 157.14%
7,200 $879,000
Q3 2022

Nov 14, 2022

BUY
$84.03 - $110.23 $8,403 - $11,023
100 Added 3.7%
2,800 $289,000
Q2 2022

Aug 08, 2022

SELL
$78.08 - $117.61 $382,592 - $576,289
-4,900 Reduced 64.47%
2,700 $251,000
Q1 2022

May 16, 2022

BUY
$102.18 - $135.75 $776,568 - $1.03 Million
7,600 New
7,600 $892,000
Q4 2021

Feb 14, 2022

SELL
$127.1 - $169.66 $355,880 - $475,048
-2,800 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$112.67 - $176.92 $90,136 - $141,536
800 Added 40.0%
2,800 $446,000
Q2 2021

Aug 16, 2021

BUY
$121.62 - $145.29 $36,486 - $43,587
300 Added 17.65%
2,000 $263,000
Q1 2021

May 17, 2021

SELL
$124.92 - $173.33 $124,920 - $173,330
-1,000 Reduced 37.04%
1,700 $219,000
Q4 2020

Feb 16, 2021

BUY
$151.2 - $182.76 $408,239 - $493,452
2,700 New
2,700 $450,000

Others Institutions Holding ASND

About Ascendis Pharma A/S


  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $7.61B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.